Login/Sign Up

MRP ₹74995
(Inclusive of all Taxes)
₹11249.3 Cashback (15%)
Sigrima 420 mg Injection 14 ml is used in the treatment of Breast cancer. It contains Pertuzumab as an active ingredient, which belongs to the class of monoclonal antibodies. It works by inhibiting the excess production of a human epidermal growth factor receptor 2 (HER2) protein in mammalian cells; this causes inhibition of the cancer cell growth and, finally, initiating apoptosis. Sigrima 420 mg Injection 14 ml is known to cause embryo-fetal toxicity. Hence, if you are pregnant or breastfeeding, inform your doctor beforehand.
Provide Delivery Location
About Sigrima 420 mg Injection 14 ml
Sigrima 420 mg Injection 14 ml is an anti-cancer medicine used in the treatment of Breast cancer. Cancer is a disease where the cells grow abnormally and divide uncontrollably. The abnormal growth of cancer (malignant) cells in the breast is known as breast cancer. Sigrima 420 mg Injection 14 ml is combined with trastuzumab and docetaxel for treating patients with HER2-positive metastatic breast cancer who have not received any chemotherapy for metastatic breast cancer. This medicine is also used in combination with docetaxel and trastuzumab as a neoadjuvant treatment of breast cancer in patients with HER2-positive (human epidermal growth factor receptor 2) or as part of a complete treatment regimen for early breast cancer.
Sigrima 420 mg Injection 14 ml contains Pertuzumab as a active ingredient which belongs to the class of monoclonal antibodies. It works by inhibiting the excess production of a human epidermal growth factor receptor 2 (HER2) protein in the mammalian cells. This causes inhibition of the cancer cell growth and, finally, initiation of apoptosis.
Sigrima 420 mg Injection 14 ml may cause certain side effects such as fatigue, nausea, headache, vomiting, dizziness, hair loss, constipation, dry skin, myalgia, upper respiratory tract infections, diarrhea, and pain at the site of injection. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor. A trained healthcare doctor will administer Sigrima 420 mg Injection 14 ml. So, do not self-administer. Your doctor will decide the dose of the medicine based on your health condition.
Sigrima 420 mg Injection 14 ml should be avoided if you are allergic to it or any other components of this medicine. Sigrima 420 mg Injection 14 ml may cause left ventricular dysfunction, anaphylaxis, or hypersensitivity reactions during the treatment. Hence, careful observation should be performed for any reactions in the patient. If any changes or hypersensitivity reactions occur, treatment should be discontinued. Inform your doctor if you have any cardiovascular conditions or liver/kidney disease, as it can cause adverse effects. Sigrima 420 mg Injection 14 ml is known to cause embryo-fetal toxicity. Hence, if you are pregnant or breastfeeding, inform your doctor beforehand. The use of Sigrima 420 mg Injection 14 ml along with the doxorubicin-containing regimen is not established. Hence, if you are on such treatment, inform your doctor before starting the treatment. Sigrima 420 mg Injection 14 ml is not recommended for use in children as the safety and efficacy are not established.
Uses of Sigrima 420 mg Injection 14 ml
Sigrima 420 mg Injection 14 ml is used in the treatment of Breast Cancer. The detailed uses of Sigrima 420 mg Injection 14 ml are as follows:

Have a query?
Directions for Use
Medicinal Benefits
Sigrima 420 mg Injection 14 ml contains Pertuzumab, which belongs to the class of monoclonal antibodies. It works by inhibiting the excess production of a human epidermal growth factor receptor 2 (HER2) protein in the mammalian cells. This causes inhibition of the cancer cell growth and, finally, initiation of apoptosis. Sigrima 420 mg Injection 14 ml is used in combination with trastuzumab and docetaxel for the treatment of breast cancer.
How Sigrima 420 mg Injection 14 ml Works
Storage
What if I have taken an overdose of Sigrima 420 mg Injection 14 ml
Drug Warnings
Sigrima 420 mg Injection 14 ml should be avoided if you are allergic to it or any other components of this medicine. Sigrima 420 mg Injection 14 ml may cause left ventricular dysfunction, anaphylaxis, or hypersensitivity reactions during the treatment. Hence, careful observation should be performed for any reactions in the patient. If any changes or hypersensitivity reactions occur, treatment should be discontinued. Inform your doctor if you have any cardiovascular conditions or liver/kidney disease, as it can cause adverse effects. Sigrima 420 mg Injection 14 ml is known to cause embryo-fetal toxicity. Hence, if you are pregnant or breastfeeding, inform your doctor beforehand. The use of Sigrima 420 mg Injection 14 ml along with the doxorubicin-containing regimen is not established. Hence, if you are on such treatment, inform your doctor before starting the treatment. Sigrima 420 mg Injection 14 ml is not recommended for use in children as the safety and efficacy are not established.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
RXAlkem Laboratories Ltd
₹29000
(₹2071.43/ 1ml)
RXHetero Healthcare Ltd
₹29990
(₹2142.14/ 1ml)
RXDr Reddy's Laboratories Ltd
₹74992.5
(₹5356.61/ 1ml)
Alcohol
Unsafe
Alcohol intake might increase the risk of worsening your condition. Hence, avoid alcohol consumption till your condition improves.
Pregnancy
Unsafe
Sigrima 420 mg Injection 14 ml is not recommended for use in pregnancy as it may harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Sigrima 420 mg Injection 14 ml. Use reliable methods of birth control while on treatment with Sigrima 420 mg Injection 14 ml.
Breast Feeding
Caution
It is not known whether Sigrima 420 mg Injection 14 ml is excreted in breast milk. Hence, if you are breastfeeding, inform your doctor before receiving Sigrima 420 mg Injection 14 ml. Your doctor will weigh the benefits and the risks before prescribing this medicine.
Driving
Caution
Sigrima 420 mg Injection 14 ml will be administered in the hospital setting. Driving is not recommended while on therapy.
Liver
Caution
No clinical trials have assessed the impact of hepatic impairment on the pharmacokinetics of Sigrima 420 mg Injection 14 ml. Hence, if you have a pre-existing or a history of liver disease, inform your doctor.
Kidney
Caution
Limited data are available on the effect of Sigrima 420 mg Injection 14 ml in kidney-impaired patients. Hence, if you have a pre-existing or a history of kidney disease, inform your doctor.
Children
Unsafe
Sigrima 420 mg Injection 14 ml is not recommended for use in children as the safety and efficacy are not established.
Heart
Sigrima 420 mg Injection 14 ml may increase the risk of heart problems. Therefore, please inform your doctor if you have any heart-related problems before using Sigrima 420 mg Injection 14 ml.
Geriatrics
Safe if prescribed
Sigrima 420 mg Injection 14 ml is generally considered safe when used under medical supervision in geriatric patients; however, significant precautions should be taken due to age-related sensitivities.
Sigrima 420 mg Injection 14 ml is used to treat Breast Cancer.
Sigrima 420 mg Injection 14 ml contains Pertuzumab, which works by inhibiting the excess production of a protein called human epidermal growth factor receptor 2 (HER2) in mammalian cells. This causes inhibition of the cancer cell growth and, finally, initiation of apoptosis.
Inform your doctor whether you have received any other breast cancer treatment containing doxorubicin in your medication list. Sigrima 420 mg Injection 14 ml may cause left ventricular dysfunction, anaphylaxis, hypersensitivity reactions, and embryo-fetal toxicity during the treatment. Hence, inform your oncologist if you have any cardiovascular conditions, liver/kidney disease, are pregnant, are planning to become pregnant, or are breastfeeding before receiving Sigrima 420 mg Injection 14 ml.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Celon Laboratories Pvt Ltd
Natco Pharma Ltd
Cipla Ltd
Adley Formulations
BDR Pharmaceuticals Internationals Pvt Ltd
Sun Pharmaceutical Industries Ltd
Admac Lifesciences(Oncology)
Halsted Pharma Pvt Ltd
Glenmark Pharmaceuticals Ltd
Neon Laboratories Ltd
United Biotech Pvt Ltd
Alkem Laboratories Ltd
Samarth Life Sciences Pvt Ltd
Zydus Cadila
Zydus Healthcare Ltd
Emcure Pharmaceuticals Ltd
Axiommax Oncology Pvt Ltd
GLS Pharma Ltd
Mylan Pharmaceuticals Pvt Ltd
Hetero Drugs Ltd
Hetero Healthcare Pvt Ltd
Fresenius Kabi India Pvt Ltd
Pfizer Ltd
Torrent Pharmaceuticals Ltd
Cadila Healthcare Ltd
Getwell Life Sciences India Pvt Ltd
Therdose Pharma Pvt Ltd
Khandelwal Laboratories Pvt Ltd
Novartis India Ltd
Lupin Ltd
Adley Pharmaceuticals Ltd
Aureate Healthcare
Biochem Pharmaceutical Industries Ltd
RPG Life Sciences Ltd
Abbott India Ltd
Delarc Pharmaceuticals Pvt Ltd
Zee Laboratories Ltd
Amps Biotech Biotech Pvt Ltd
Shilpa Medicare Ltd
Wembrace Biopharma Pvt Ltd
Aimcad Biotech Pvt Ltd
Getwell Oncology Pvt Ltd
Msn Laboratories Pvt Ltd
Reliance Formulation Pvt Ltd
Allieva Pharma Pvt Ltd
Astra Zeneca Pharma India Ltd
Lucien Life Sciences
Getwell Pharmaceutical Pvt Ltd
MEDICAMEN BIOTECH LTD
Medion Biotech Pvt Ltd
Bhardwaj India Pvt Ltd
Caitlin Oncology
Del Trade International Pvt Ltd
Medaegis Biotek Pvt Ltd
Panacea Biotec Ltd
Cadila Pharmaceuticals Ltd
Dabur India Ltd
Oncostar Pharma Pvt Ltd
Sarabhai Chemicals (India) Pvt Ltd
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Cytogen
Symbion Lifescience
Vhb Life Sciences Inc
Zuvius Lifesciences Pvt Ltd
Amneal Healthcare Pvt Ltd
Ipca Laboratories Ltd
Miracalus Pharma Pvt Ltd
Bruck Pharma Pvt Ltd
Eli Lilly and Company (India) Pvt Ltd
Hilfen Pharmaceuticals Pvt Ltd
Medicamen Biotech Ltd
Adley Oncology
Admac Pharma Ltd
Eris Life Sciences Ltd
Johnson & Johnson Pvt Ltd
Maximal Healthcare Pvt Ltd
Reliance Life Sciences Pvt Ltd
Sayre Therapeutics Pvt Ltd
Akumentis Healthcare Ltd
Biocon Ltd
Caitlin Biotech Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Zuventus Healthcare Ltd
Astellas Pharma India Pvt Ltd
Boehringer Ingelheim India Pvt Ltd
Mankind Pharma Pvt Ltd
Roche Diagnostics India Pvt Ltd
Selway Lifesciences Pvt Ltd
Trikem Remedies Llp
Adley & Bdl
Aprazer Healthcare Pvt Ltd
Aureate Pharma
Caitlin Life Care
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Gynofem Healthcare Pvt Ltd